Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. May 10, 2011; 2(5): 195-202
Published online May 10, 2011. doi: 10.5306/wjco.v2.i5.195
Published online May 10, 2011. doi: 10.5306/wjco.v2.i5.195
Figure 3 Pancreas epithelium-specific KrasG12D expression.
Cre recombinase is expressed under the promoter of PDX1 or Ptf1a gene, which is pancreas epithelium-specific. Without cre recombinase expression, a stop sequence between the loxP sites prevents mutant KrasG12D expression. In cells where only cre recombinase is expressed, the stop sequence is cut out, which turns on the pancreas epithelium-specific KrasG12D expression at a physiological level under the native Kras promoter.
- Citation: Ijichi H. Genetically-engineered mouse models for pancreatic cancer: Advances and current limitations. World J Clin Oncol 2011; 2(5): 195-202
- URL: https://www.wjgnet.com/2218-4333/full/v2/i5/195.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i5.195